<DOC>
	<DOCNO>NCT01325792</DOCNO>
	<brief_summary>Prospective , multicenter , observational study evaluate performance GORE® BIO-A® Tissue Reinforcement use reinforce midline fascial closure single-staged open complex ventral incisional hernia repair .</brief_summary>
	<brief_title>Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material Midline Fascial Closure Reinforcement</brief_title>
	<detailed_description>The study evaluate performance biosynthetic mesh use reinforce midline fascial closure single-staged open complex ventral incisional hernia repair . It design test null hypothesis two year recurrence rate associate device great equal 50 % vs alternative hypothesis two year recurrence rate le 50 % .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Incisional Hernia</mesh_term>
	<criteria>Subjects inform study , read ; understood sign informed consent authorization use PHI , applicable Subjects willing able submit postoperative followup evaluation include quality life assessment 24 month surgery Subjects either gender least age 18 year Subjects BodyMass Index ( BMI ) &lt; 40 Subjects undergo singlestaged open complex ventral incisional hernia repair retrorectus intraperitoneal placement technique GORE® BIOA® Tissue Reinforcement Subjects intraoperatively surgical field/wound characterize either Type 2 Type 3 Table 1 Section 12.0 Subjects hernia defect &gt; 9 cm2 large measure intraoperatively Subjects require mobility midline fascial closure without excessive tension reapproximate rectus abdominis muscle intraoperatively achieve Subjects one unit GORE® BIOA® Tissue Reinforcement adequately reinforce midline fascial closure least 4 cm overlap laterally Subjects , surgeon 's opinion , would difficult time comprehend comply requirement study Subjects BMI &gt; 40 Subjects evidence preexist systemic infection Subjects cirrhosis currently treat dialysis Subjects woundhealing disorder Subjects autoimmune disorder require &gt; 10mg corticosteroid per day Subjects immunocompromised , HIV transplant , receive chemo radiation therapy Subjects hernia defect &lt; 9 cm2 large measure intraoperatively Subjects hernia defect require one unit GORE® BIOA® Tissue Reinforcement Subjects intraoperatively inability achieve retrorectus intraperitoneal placement device Subjects midline fascial closure without excessive tension achieve Subjects intraoperatively surgical field/wound characterize either Type 1 Type 4 Table 1 Section 12 Subjects need concomitant surgical procedure indicate protocol acceptable Subject complex ventral incisional hernia repair require one operation reduce hernia close fascia , include serial excision procedure require subsequent surgery complete hernia repair Subjects hernia repair require emergent procedure , strangulate bowel Subjects intraoperatively untreated cancer find</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Complex ventral incisional hernia repair</keyword>
	<keyword>reapproximation rectus abdominis muscle</keyword>
	<keyword>retrorectus intraperitoneal placement technique</keyword>
	<keyword>mobility midline fascial closure</keyword>
</DOC>